Close

Natus Medical, Inc. (BABY) Tops Q3 EPS by 2c; Bumps Outlook

October 22, 2014 7:22 AM EDT

Natus Medical, Inc. (NASDAQ: BABY) reported Q3 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $89.9 million versus the consensus estimate of $87.3 million.

Natus Medical, Inc. sees Q4 2014 EPS of $0.37-$0.39 versus the consensus of $0.38. Natus Medical, Inc. sees Q4 2014 revenue of $92-94 million, versus the consensus of $91.8 million.

Natus Medical, Inc. sees FY2014 EPS of $1.23-$1.25, versus prior guidance of $1.2-$1.23 and the consensus of $1.22. Natus Medical, Inc. sees FY2014 revenue of $353.8-355.8 million, versus prior guidance of $347.5-$352.5 million and the consensus of $351.53 million.

"I am very pleased with our third quarter results as we achieved record revenues and earnings. Both revenue and earnings exceeded the top end of guidance. I am most satisfied with our 63% gross profit margin as well as recording over 5% organic revenue growth. Consistent organic revenue growth and improving margins have been major goals for Natus in 2014 and our results demonstrate significant progress to the achievement of these goals," said Jim Hawkins, President and Chief Executive Officer of the Company.

"I remain excited about our Peloton Hearing Screening Service business as we added 17 hospitals during the quarter and we ended the quarter with 39 hospitals under contact. Including contracts already signed during October, we have exceeded our 2014 goal of 40 hospitals under contract by the end of the year," Mr. Hawkins continued.

For earnings history and earnings-related data on Natus Medical, Inc. (BABY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Management Comments

Related Entities

Earnings